Regulatory Updates
Aug 24, 2026•1 min read
FDA Grants ANDA Approval for Ciprofloxacin Hydrochloride Tablets (ANDA 076593)
The FDA approved generic ciprofloxacin hydrochloride tablets (250 mg, 500 mg, 750 mg) under ANDA 076593, sponsored by Aiping Pharm and manufactured by Westminster Pharmaceuticals.
Regulatory Updates
Aug 24, 2026•1 min read
FDA Approves LIDOCAINE AND PRILOCAINE Topical Cream (ANDA076320)
The FDA approved ANDA076320 for a prescription topical cream containing 2.5% lidocaine and 2.5% prilocaine, manufactured by Encube Ethicals.
3
Regulatory Updates
Aug 24, 2026•1 min read
Hikma Pharm's Rosiglitazone Maleate Tablet ANDA Receives Tentative Approval (ANDA078658)
FDA granted tentative approval to Hikma Pharm's ANDA078658 for three oral rosiglitazone maleate tablet strengths (2 mg, 4 mg, 8 mg).
Regulatory Updates
Aug 24, 2026•1 min read
FDA Approves Dr. Reddy's DESLORATADINE Oral Disintegrating Tablets (ANDA 078367)
The FDA has approved Dr. Reddy's Laboratories' DESLORATADINE oral disintegrating tablets in 2.5 mg and 5 mg strengths under ANDA 078367.